Completed
Topics
An IOM committee will review the published literature to identify appropriate evaluation criteria for tests based on "omics" technologies (e.g. genomics, epigenomics, proteomics, metabolomics) that are used as predictors of clinical outcomes. The committee will recommend an evaluation process for determining when predictive tests based on omics technologies are fit for use as a basis for clinical trial design, including stratification of patients and response to therapy in clinical trials.
Events
Meetings
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.
About
Get in touch
Our People